{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:06:31Z","timestamp":1783130791133,"version":"3.54.6"},"reference-count":43,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.3892\/ol.2015.3436","type":"journal-article","created":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T07:47:12Z","timestamp":1435650432000},"page":"1271-1276","source":"Crossref","is-referenced-by-count":16,"title":["Expression of cyclin D1 and cyclin E in urothelial bladder carcinoma detected in tissue chips using a quantum dot immunofluorescence technique"],"prefix":"10.3892","volume":"10","author":[{"given":"GUANG","family":"SHAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TIAN","family":"TANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,6,30]]},"reference":[{"key":"key20180108100048_b1-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"key20180108100048_b2-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1158\/1078-0432.CCR-04-0930","article-title":"Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients","volume":"10","author":"Friedrich","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180108100048_b3-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/1596-3519.82071","article-title":"Incidence of bladder cancer in a one-stop clinic","volume":"10","author":"Yakasai","year":"2011","journal-title":"Ann Afr Med"},{"key":"key20180108100048_b4-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1586\/epr.11.28","article-title":"Back to the future in bladder cancer research","volume":"8","author":"Vlahou","year":"2011","journal-title":"Expert Rev Proteomics"},{"key":"key20180108100048_b5-ol-0-0-3436","first-page":"1722","article-title":"Expression and clinical significance of RECK and MT1-MMP in bladder urothelium carcinoma tissues","volume":"19","author":"Shan","year":"2012","journal-title":"Chin J Cancer Prev Treat"},{"key":"key20180108100048_b6-ol-0-0-3436","first-page":"268","article-title":"Expression and clinical sigificance of cyclin G1 and cyclin G2 in transitional cell carcinoma of bladder","volume":"18","author":"Shan","year":"2009","journal-title":"Chinese J Histochem Cytochem"},{"key":"key20180108100048_b7-ol-0-0-3436","first-page":"267","article-title":"Expression and clinical sigificance of ADO in transitional cell carcinoma of bladder","volume":"20","author":"Shan","year":"2011","journal-title":"Chinese J Histochem Cytochem"},{"key":"key20180108100048_b8-ol-0-0-3436","first-page":"491","article-title":"Expression and clinical sigificance of tumor suppressor genes DPC4 and TGF-\u03b21 in transitional cell carcinoma of bladder","volume":"20","author":"Shan","year":"2011","journal-title":"Chinese J Histochem Cytochem"},{"key":"key20180108100048_b9-ol-0-0-3436","first-page":"185","article-title":"Expression and clinical sigificance of CD82\/KAI1 in transitional cell carcinoma of bladder","volume":"22","author":"Shan","year":"2013","journal-title":"Chinese J Histochem Cytochem"},{"key":"key20180108100048_b10-ol-0-0-3436","first-page":"684","article-title":"Expression and clinical significance of PSCA and mesothelin in transitional cell carcinoma of bladder","volume":"6","author":"Shan","year":"2010","journal-title":"Chinese J Histochem Cytochem"},{"key":"key20180108100048_b11-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/j.bpj.2011.04.014","article-title":"The role of the LH subdomain in the function of the Cip\/Kip cyclin-dependent kinase regulators","volume":"100","author":"Otieno","year":"2011","journal-title":"Biophys J"},{"key":"key20180108100048_b12-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature10155","article-title":"A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers","volume":"474","author":"Jirawatnotai","year":"2011","journal-title":"Nature"},{"key":"key20180108100048_b13-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0304-3835(99)00421-8","article-title":"Cyclin E overexpression in transitional cell carcinoma of the bladder","volume":"151","author":"Makiyama","year":"2000","journal-title":"Cancer Lett"},{"key":"key20180108100048_b14-ol-0-0-3436","first-page":"1235","article-title":"Cyclin E expression is a signifieant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study","volume":"63","author":"Farley","year":"2003","journal-title":"Cancer Res"},{"key":"key20180108100048_b15-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/blood.V87.8.3360.bloodjournal8783360","article-title":"Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage","volume":"87","author":"Scuderi","year":"1996","journal-title":"Blood"},{"key":"key20180108100048_b16-ol-0-0-3436","volume-title":"Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs","author":"Eble","year":"2004"},{"key":"key20180108100048_b17-ol-0-0-3436","first-page":"262","volume-title":"TNM Classification of Malignant Tumors UICC International Union Against Cancer","author":"Sobin","year":"2009","edition":"7th"},{"key":"key20180108100048_b18-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10735-009-9237-y","article-title":"Comparison of quantum dots immunofluorescence histochemistry and conventional immunohistochemistry for the detection of caveolin-1 and PCNA in the lung cancer tissue microarray","volume":"40","author":"Chen","year":"2009","journal-title":"J Mol Hist"},{"key":"key20180108100048_b19-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3892\/etm.2015.2287","article-title":"Study on extracellular matrix metalloproteinase inducer and human epidermal growth factor receptor-2 protein expression in papillary thyroid carcinoma using a quantum dot-based immunofluorescence technique","volume":"9","author":"Tang","year":"2015","journal-title":"Exp Ther Med"},{"key":"key20180108100048_b20-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"key20180108100048_b21-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"key20180108100048_b22-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1158\/0008-5472.CAN-12-2101","article-title":"Targeting folate receptors to treat invasive urinary bladder cancer","volume":"73","author":"Dhawan","year":"2013","journal-title":"Cancer Res"},{"key":"key20180108100048_b23-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"466475","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"key20180108100048_b24-ol-0-0-3436","first-page":"91","article-title":"Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P3 and IGF2-P4 regulatory sequences","volume":"4","author":"Amit","year":"2011","journal-title":"Int J Clin Exp Med"},{"key":"key20180108100048_b25-ol-0-0-3436","first-page":"381","article-title":"Correlation of cyclin D1 expression with aggressive DNA pattern in patients with tobacco-related intraoral squamous cell carcinoma","volume":"133","author":"Das","year":"2011","journal-title":"Indian J Med Res"},{"key":"key20180108100048_b26-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/1439-7641(20010119)2:1<20::AID-CPHC20>3.0.CO;2-R","article-title":"Quantum dots as chemical building blocks: elementary theoretical considerations","volume":"2","author":"Remacle","year":"2001","journal-title":"Chemphyschem"},{"key":"key20180108100048_b27-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.bbrc.2006.07.160","article-title":"Water-soluble quantum dots for biomedical applications","volume":"348","author":"Yu","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108100048_b28-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/wnan.14","article-title":"Magnetic quantum dots for multimodal imaging","volume":"1","author":"Koole","year":"2009","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"key20180108100048_b29-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3109\/00016489.2011.557393","article-title":"Human telomerase reverse transcriptase regulates cyclin D1 and G1\/S phase transition in laryngeal squamous carcinoma","volume":"131","author":"Li","year":"2011","journal-title":"Acta Otolaryngol"},{"key":"key20180108100048_b30-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/annonc\/mdf215","article-title":"Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy","volume":"13","author":"Hwang","year":"2002","journal-title":"Ann Oncol"},{"key":"key20180108100048_b31-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ijc.10151","article-title":"Over expression of cyclin D1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients","volume":"98","author":"Umekita","year":"2002","journal-title":"Int J Cancer"},{"key":"key20180108100048_b32-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1477-7819-8-111","article-title":"Cell cyclins: triggering elements of cancer or not?","volume":"8","author":"Stamatakos","year":"2010","journal-title":"World J Surg Oncol"},{"key":"key20180108100048_b33-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1158\/1940-6207.CAPR-10-0297","article-title":"Cyclin E transgenic mice: discovery tools for lung cancer biology, therapy and prevention","volume":"3","author":"Freemantle","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"key20180108100048_b34-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mce.2010.03.017","article-title":"Cyclins and their related proteins in pituitary tumourigenesis","volume":"326","author":"Musat","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"key20180108100048_b35-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3835(01)00403-7","article-title":"Reciprocal expressions of cyclin E and cyclin D1 in hepatocellular carcinoma","volume":"168","author":"Jung","year":"2001","journal-title":"Cancer Lett"},{"key":"key20180108100048_b36-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.4161\/cc.3.12.1279","article-title":"Regulation of cyclin E protein levels through E2F-mediated inhibition of degradation","volume":"3","author":"Pajalunga","year":"2004","journal-title":"Cell Cycle"},{"key":"key20180108100048_b37-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0002-9440(10)64592-0","article-title":"High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer","volume":"157","author":"Richter","year":"2000","journal-title":"Am J Pathol"},{"key":"key20180108100048_b38-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/hupa.2001.27116","article-title":"Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma","volume":"32","author":"Li","year":"2001","journal-title":"Hum Pathol"},{"key":"key20180108100048_b39-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/hupa.2001.21141","article-title":"Cyclin E immunoexpression in breast ductal cancinoma: pathologic correlations and prognostic implications","volume":"32","author":"Donnellan","year":"2001","journal-title":"Hum Pathol"},{"key":"key20180108100048_b40-ol-0-0-3436","first-page":"86","article-title":"Cyclin E and tumor","volume":"20","author":"Zhu","year":"2003","journal-title":"Chinese Medical Journal of Zhong Guo Yejin Gongye Yixue Zazhi"},{"key":"key20180108100048_b41-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1046\/j.1523-1747.1999.00812.x","article-title":"High levels of expression of p27KIPl and cyclin E in invasive primary malignant melanomas","volume":"113","author":"Bales","year":"1999","journal-title":"J Invest Dermatol"},{"key":"key20180108100048_b42-ol-0-0-3436","first-page":"481","article-title":"Processing of cyclin E differs between normal and tumor breast cells","volume":"60","author":"Harwell","year":"2000","journal-title":"Cancer Res"},{"key":"key20180108100048_b43-ol-0-0-3436","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4161\/cc.11.1.18775","article-title":"An integrated view of cyclin E function and regulation","volume":"11","author":"Siu","year":"2012","journal-title":"Cell Cycle"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2015.3436\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T08:21:28Z","timestamp":1599207688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2015.3436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,30]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,6,30]]},"published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.3892\/ol.2015.3436"],"URL":"https:\/\/doi.org\/10.3892\/ol.2015.3436","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,30]]}}}